Alternatives
Alternatives to Tyenne 200 mg/10 mL injection
There are 3 alternatives to this medicine in the catalogue: the same active ingredient (Tocilizumab), strength (200 mg/10 mL) and dosage form (injection) from 3 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Tyenne 200 mg/10 mL injectionThis pageIntravenous | Fresenius Kabi | US FDA | 1 vial of 10 mL | Cold chain | On request | — | Available on request |
| Tofidence 200 mg/10 mL injectionIntravenous | Biogen MA | US FDA | 1 vial of 10 mL, 1 vial of 10 mL | Cold chain | On request | — | Available on request |
| Avtozma 200 mg/10 mL injectionIntravenous | Celltrion | US FDA | 1 vial of 10 mL, 4 vials of 10 mL | Cold chain | On request | — | Available on request |
| Actemra 200 mg/10 mL injectionIntravenous | Genentech | US FDA | 1 vial of 10 mL | Cold chain | On request | — | Available on request |
This is a biological medicine. Products from other makers are biosimilars, not identical copies, and switching between them follows the prescriber's and regulator's rules.
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Tyenne 200 mg/10 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.